Cargando…
Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
BACKGROUND: The national comprehensive cancer network defines adequate lymphadenectomy as evaluation of ≥ 15 lymph nodes in esophageal cancer. However, varying thresholds have been suggested following neoadjuvant therapy. OBJECTIVES: Our objectives were to (1) explore trends in adequate lymphadenect...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282211/ https://www.ncbi.nlm.nih.gov/pubmed/32519142 http://dx.doi.org/10.1245/s10434-020-08578-4 |
_version_ | 1783544087731765248 |
---|---|
author | Schlick, Cary Jo R. Khorfan, Rhami Odell, David D. Merkow, Ryan P. Bentrem, David J. |
author_facet | Schlick, Cary Jo R. Khorfan, Rhami Odell, David D. Merkow, Ryan P. Bentrem, David J. |
author_sort | Schlick, Cary Jo R. |
collection | PubMed |
description | BACKGROUND: The national comprehensive cancer network defines adequate lymphadenectomy as evaluation of ≥ 15 lymph nodes in esophageal cancer. However, varying thresholds have been suggested following neoadjuvant therapy. OBJECTIVES: Our objectives were to (1) explore trends in adequate lymphadenectomy rates over time; (2) evaluate unadjusted lymphadenectomy yield by treatment characteristics; and (3) identify independent factors associated with adequate lymphadenectomy. METHODS: The National Cancer Data Base was used to identify patients who underwent esophagectomy for cancer from 2004 to 2015. Adequate lymphadenectomy trends over time were evaluated using the Cochrane–Armitage test, and lymph node yield by treatment approach was compared using the Mann–Whitney U and Kruskal–Wallis tests. Associations with treatment factors were assessed by multivariable logistic regression. RESULTS: Among 24,413 patients, 9919 (40.6%) had adequate lymphadenectomy. Meeting the nodal threshold increased over time (52.6% in 2015 vs. 26.0% in 2004; p < 0.01). Lymph node yield did not differ based on neoadjuvant therapy (median 12 [interquartile range 7–19] with and without neoadjuvant therapy; p = 0.44). Adequate lymphadenectomy was not associated with neoadjuvant therapy (40.5% vs. 40.8%, odds ratio [OR] 0.94, 95% confidence interval [CI] 0.82–1.07), but was associated with surgical approach (52.7% of laparoscopic cases, OR 1.28, 95% CI 1.06–1.56; 61.2% of robotic cases, OR 1.71, 95% CI 1.34–2.19, vs. 43.5% of open cases), and increasing annual esophagectomy volume (55.6% in the fourth quartile vs. 32.6% in the first quartile; OR 3.57, 95% CI 2.35–5.43). CONCLUSIONS: Despite increases over time, only 50% of patients undergo adequate lymphadenectomy during esophageal cancer resection. Adequate lymphadenectomy was not associated with neoadjuvant therapy. Focusing on surgical approach and esophagectomy volume may further improve adequate lymphadenectomy rates. |
format | Online Article Text |
id | pubmed-7282211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-72822112020-06-09 Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? Schlick, Cary Jo R. Khorfan, Rhami Odell, David D. Merkow, Ryan P. Bentrem, David J. Ann Surg Oncol Thoracic Oncology BACKGROUND: The national comprehensive cancer network defines adequate lymphadenectomy as evaluation of ≥ 15 lymph nodes in esophageal cancer. However, varying thresholds have been suggested following neoadjuvant therapy. OBJECTIVES: Our objectives were to (1) explore trends in adequate lymphadenectomy rates over time; (2) evaluate unadjusted lymphadenectomy yield by treatment characteristics; and (3) identify independent factors associated with adequate lymphadenectomy. METHODS: The National Cancer Data Base was used to identify patients who underwent esophagectomy for cancer from 2004 to 2015. Adequate lymphadenectomy trends over time were evaluated using the Cochrane–Armitage test, and lymph node yield by treatment approach was compared using the Mann–Whitney U and Kruskal–Wallis tests. Associations with treatment factors were assessed by multivariable logistic regression. RESULTS: Among 24,413 patients, 9919 (40.6%) had adequate lymphadenectomy. Meeting the nodal threshold increased over time (52.6% in 2015 vs. 26.0% in 2004; p < 0.01). Lymph node yield did not differ based on neoadjuvant therapy (median 12 [interquartile range 7–19] with and without neoadjuvant therapy; p = 0.44). Adequate lymphadenectomy was not associated with neoadjuvant therapy (40.5% vs. 40.8%, odds ratio [OR] 0.94, 95% confidence interval [CI] 0.82–1.07), but was associated with surgical approach (52.7% of laparoscopic cases, OR 1.28, 95% CI 1.06–1.56; 61.2% of robotic cases, OR 1.71, 95% CI 1.34–2.19, vs. 43.5% of open cases), and increasing annual esophagectomy volume (55.6% in the fourth quartile vs. 32.6% in the first quartile; OR 3.57, 95% CI 2.35–5.43). CONCLUSIONS: Despite increases over time, only 50% of patients undergo adequate lymphadenectomy during esophageal cancer resection. Adequate lymphadenectomy was not associated with neoadjuvant therapy. Focusing on surgical approach and esophagectomy volume may further improve adequate lymphadenectomy rates. Springer International Publishing 2020-06-09 2020 /pmc/articles/PMC7282211/ /pubmed/32519142 http://dx.doi.org/10.1245/s10434-020-08578-4 Text en © Society of Surgical Oncology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Thoracic Oncology Schlick, Cary Jo R. Khorfan, Rhami Odell, David D. Merkow, Ryan P. Bentrem, David J. Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? |
title | Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? |
title_full | Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? |
title_fullStr | Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? |
title_full_unstemmed | Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? |
title_short | Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach? |
title_sort | adequate lymphadenectomy as a quality measure in esophageal cancer: is there an association with treatment approach? |
topic | Thoracic Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282211/ https://www.ncbi.nlm.nih.gov/pubmed/32519142 http://dx.doi.org/10.1245/s10434-020-08578-4 |
work_keys_str_mv | AT schlickcaryjor adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach AT khorfanrhami adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach AT odelldavidd adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach AT merkowryanp adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach AT bentremdavidj adequatelymphadenectomyasaqualitymeasureinesophagealcanceristhereanassociationwithtreatmentapproach |